Tabula Rasa HealthCare Overview
Valuation check: TRHC's ROE is 78.35%, above the Consumer Staples sector average of 14.41%.
Get informed when a big investor buys or sells
+ Follow78.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Tabula Rasa HealthCare posts a ROE of 78.35%. That is above the Consumer Staples sector average of 14.41%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For Consumer Staples stocks, a ROE near 14.41% is typical. Tabula Rasa HealthCare's 78.35% is higher that level. That is roughly 443.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Tabula Rasa HealthCare's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 78.35%; use YoY and peer views to separate noise from signal.
Context for TRHC's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 14.41%), and (3) consistency with growth and profitability. This page covers the first two; Tabula Rasa HealthCare's other metric pages and overview cover the third.
Judging Tabula Rasa HealthCare against Consumer Staples peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Staples are more comparable, which makes gaps in ROE easier to interpret. Start with 78.35% here, then scan peer and history charts to see if the gap is persistent.
